Skip to main content

Patou Gary's Form 4 filing

Xenon Pharmaceuticals Inc. (XENE) · filed Dec 15, 2023

Accession no.
0000950170-23-070841
Filed
Dec 15, 2023
Trade date
Dec 13, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 10 non-derivative transactions and 3 derivative transactions. Open-market sales total $759.0K. It was filed 2 days after the trade.

This filing was later replaced by the amendment 0000950170-23-070912 (Dec 15, 2023). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Patou GaryCIK 0001283535Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 13, 2023Common SharesMOption exerciseAcquired+6,378$9.85+$62,823.329,951Direct
Dec 13, 2023Common SharesFTax withholdingDisposed−1,278$39.68−$50,711.0428,673Direct
Dec 13, 2023Common SharesSSaleDisposed−5,100$38.94−$198,59423,573Direct
Dec 13, 2023Common SharesMOption exerciseAcquired+2,880$9.85+$28,36826,453Direct
Dec 13, 2023Common SharesFTax withholdingDisposed−577$39.68−$22,895.3625,876Direct
Dec 13, 2023Common SharesSSaleDisposed−2,303$39.10−$90,047.323,573Direct
Dec 13, 2023Common SharesMOption exerciseAcquired+5,144$9.00+$46,29628,717Direct
Dec 13, 2023Common SharesFTax withholdingDisposed−1,167$39.68−$46,306.5627,550Direct
Dec 13, 2023Common SharesSSaleDisposed−3,977$39.84−$158,443.6823,573Direct
Dec 13, 2023Common SharesSSaleDisposed−7,598$41.05−$311,897.94,902Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 13, 2023Common SharesMOption exerciseDisposed−6,378$0.00$00Direct
Dec 13, 2023Common SharesMOption exerciseDisposed−2,800$0.00$00Direct
Dec 13, 2023Common SharesMOption exerciseDisposed−5,144$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)